Supplementary Table S2 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Authors

Publication Details

Published
2025-08-27
DOI
https://doi.org/10.1158/1078-0432.29996643
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplementary Table S2 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Sukjun Kim, Jung Eun Lee, Nam Suk Sim, Dahee Kim et al.
2 links
Head and Neck Cancer Studies
article

Supplementary Table S2 from A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma

Sukjun Kim, Jung Eun Lee, Nam Suk Sim, Dahee Kim, Min Hee Hong, Yoojoo Lim, Sun Och Yoon, Junha Cha, Chiyoon Oum, Insuk Lee, Hyunwook Kim, Chaeyeon Kim, Heon Song, Goeun Park, Chan‐Young Ock, Hye Ryun Kim, Hyun Jun Hong, Chang Gon Kim, Yoon Ji Bang, Seunghee Kim‐Schulze, Mingu Kang, Gamin Kim, Heejung Park, Se‐Heon Kim, Brian Hyohyoung Lee, Dawoon Han, Miriam Mérad, Geoffrey Kelly, Yoon Woo Koh, Jong Hoon Kim, Inkyung Jung, Chang Geol Lee, Hyun Je Kim, Jin Woo Park, Kyung Hwan Kim, Young Min Park, Seulki Kim
article en

Abstract

No abstract available for this paper.
Openalex Percentile: Top 70%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.